The enhanced blood residence time of C/M@Alb NCs may be attributed to prolonged half-life of Alb in the blood and the small PS (≈ 60 nm), likely empowering the in vivo targeted delivery to the tumor site [42]. Here, ALB is linked to neoplasm.